{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:00:56Z","timestamp":1778792456593,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vascn.2016.05.011","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T17:51:23Z","timestamp":1464285083000},"page":"295-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse"],"prefix":"10.1016","volume":"81","author":[{"given":"Michael D.B.","family":"Swedberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2016.05.011_bb0010","series-title":"8th World Congress on pain","volume":"455","author":"Alari","year":"1996"},{"key":"10.1016\/j.vascn.2016.05.011_bb0015","series-title":"10th World Congress on pain","first-page":"56","article-title":"Frakefamide: A peripheral active \u03bc-selective receptor agonist.","volume":"1508","author":"Alari","year":"2002"},{"key":"10.1016\/j.vascn.2016.05.011_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/10408448209041322","article-title":"Phencyclidine (PCP): A review and perspectives","volume":"10","author":"Aniline","year":"1982","journal-title":"Critical Reviews in Toxicology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0025","series-title":"Psychopharmacology: The fourth generation of progress, 95\u2013110","article-title":"Neuronal nicotinic acetylcholine receptors. Novel targets for CNS therapeutics","author":"Arneric","year":"1995"},{"key":"10.1016\/j.vascn.2016.05.011_bb0030","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/jm00140a002","article-title":"8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist","volume":"24","author":"Arvidsson","year":"1981","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.vascn.2016.05.011_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1901\/jeab.1973.20-119","article-title":"Fixed-interval schedule of cocaine reinforcement: Effect of dose and infusion duration","volume":"20","author":"Balster","year":"1973","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"10.1016\/j.vascn.2016.05.011_bb0040","series-title":"10th World Congress on Pain","first-page":"233","article-title":"Analgesia of intravenous doses of a new peripheral \u03bc-opioid receptor agonist, frakefamide, in postoperative dental pain","volume":"599","author":"Becktor","year":"2002"},{"key":"10.1016\/j.vascn.2016.05.011_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.pa.36.040196.003121","article-title":"Pharmacology of nicotine: Addiction and therapeutics","volume":"36","author":"Benowitz","year":"1996","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0050","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0028-3908(98)00139-7","article-title":"Neuropharmacology of AMPA and kainate receptors","volume":"37","author":"Bleakman","year":"1998","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF02245851","article-title":"ABT-418: Discriminative stimulus properties and effect on ventral tegmental cell activity","volume":"119","author":"Brioni","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0060","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0014-2999(81)90588-4","article-title":"UK-14,034, a potent and selective \u03b12-agonist for the characterization of \u03b1-adrenoceptor subtypes","volume":"72","author":"Cambridge","year":"1981","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0070","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/0024-3205(80)90561-5","article-title":"Minireview: The pharmacology of prazosin, a novel antihypertensive agent","volume":"27","author":"Cavero","year":"1980","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2016.05.011_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1528-1157.1991.tb04695.x","article-title":"Anticonvulsant activity of two orally active competitive N-methyl-d-aspartate antagonists, CGP37849 and CGP39551, against sound-induced seizures in DBA\/2mice and photically induced myoclonus in papio papio","volume":"32","author":"Chapman","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.vascn.2016.05.011_bb0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(25)31986-5","article-title":"Factors regulating drug cue sensitivity: Limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination","volume":"212","author":"Colpaert","year":"1980","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3565(25)33038-7","article-title":"A drug discrimination analysis of lysergic acid diethylamide (LSD): In vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist","volume":"221","author":"Colpaert","year":"1982","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0090","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/0024-3205(81)90648-2","article-title":"A lipophilic, selective \u03b11-adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino)imidazoline (ST 587)","volume":"28","author":"De Jonge","year":"1981","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2016.05.011_bb0095","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-3057(93)90508-Q","article-title":"Effects of lobeline, a nicotinic receptor agonist, on learning and memory","volume":"45","author":"Decker","year":"1993","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.vascn.2016.05.011_bb0100","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0105","series-title":"Evaluation of medicines for human use","article-title":"Guideline on the non-clinical investigation of the dependence potential of medicinal products","author":"EMA","year":"2006"},{"key":"10.1016\/j.vascn.2016.05.011_bb0110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1358\/dof.1989.014.07.95998","article-title":"Anpirtoline hydrochloride","volume":"14","author":"Engel","year":"1989","journal-title":"Drugs of the Future"},{"key":"10.1016\/j.vascn.2016.05.011_bb0115","first-page":"1040","article-title":"Pharmakologische charakterisierung von deseril, einem serotonin-antagonisten","volume":"37","author":"Fanchamps","year":"1960","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1016\/j.vascn.2016.05.011_bb0120","series-title":"Guidance for industry, assessment of abuse potential of drugs, Draft Guidance, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); January","author":"FDA","year":"2010"},{"key":"10.1016\/j.vascn.2016.05.011_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00518776","article-title":"MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors","volume":"326","author":"Fozard","year":"1984","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb9700","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(84)90618-6","article-title":"Idazoxan (RX 7811194) selectively antagonizes \u03b12-adrenoceptors on rat central neurons","volume":"105","author":"Freedman","year":"1984","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0130","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0024-3205(84)90164-4","article-title":"Discriminative stimulus properties of the serotonin agonist I-(3-trifluoromethylphenyl)piperazine (TFMPP)","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2016.05.011_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0028-3908(76)90026-5","article-title":"Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour","volume":"15","author":"Green","year":"1976","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0028-3908(84)90147-3","article-title":"The behavioral effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants","volume":"23","author":"Green","year":"1984","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00500769","article-title":"RX781094, a new potent\u03b1 2 adrenoceptor antagonist. In vivo and in vitro studies in the rabbit","volume":"322","author":"Hannah","year":"1983","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0150","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"187","article-title":"Catecholamines and sympathomimetic drugs","author":"Hoffman","year":"1990"},{"key":"10.1016\/j.vascn.2016.05.011_bb0155","series-title":"Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals M3(R2), current step 4 version; 11 June","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline","author":"ICH","year":"2009"},{"key":"10.1016\/j.vascn.2016.05.011_bb0160","series-title":"10th World Congress on Pain","first-page":"234","article-title":"Analgesia of a new peripheral \u03bc-opioid receptor agonist, frakefamide, following anterior cruciate ligament repair","volume":"600","author":"Jacobsson","year":"2002"},{"key":"10.1016\/j.vascn.2016.05.011_bb0165","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"485","article-title":"Opioid analgesics and antagonists","author":"Jaffe","year":"1990"},{"key":"10.1016\/j.vascn.2016.05.011_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02247426","article-title":"Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease","volume":"108","author":"Jones","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuroimage.2012.02.085","article-title":"Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers","volume":"61","author":"K\u00e5gedal","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.vascn.2016.05.011_bb0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1034\/j.1399-6576.1999.430515.x","article-title":"Sameridine - intrathecal injection in the rat. Morphometric and morphologic analysis after chronic administration and effects on spinal cord blood flow","volume":"43","author":"Karlst\u00e9n","year":"1999","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.vascn.2016.05.011_bb0190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-3565(25)24082-4","article-title":"MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys","volume":"245","author":"Koek","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(25)13197-2","article-title":"N-methyl-d-aspartate antagonism and phencyclidine-like activity: A drug discrimination analysis","volume":"253","author":"Koek","year":"1990","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0200","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1023\/A:1012144232666","article-title":"Rat Jejunal permeability and metabolism of \u03bc-selective tetrapeptides in gastrointestinal fluids from humans and rats","volume":"14","author":"Krondahl","year":"1997","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.vascn.2016.05.011_bb0205","first-page":"1207","article-title":"The local anesthetic sameridine is a selective ligand and partial agonist at cloned human mu receptors","volume":"23","author":"LaBarre","year":"1997","journal-title":"Society for Neuroscience \u2013 Abstracts"},{"key":"10.1016\/j.vascn.2016.05.011_bb0210","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/jm50001a022","article-title":"Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors","volume":"28","author":"Lauridsen","year":"1985","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.vascn.2016.05.011_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000110372","article-title":"Smoking and Alzheimer's disease: A review of the epidemiological evidence","volume":"13","author":"Lee","year":"1994","journal-title":"Neuroepidemiol."},{"key":"10.1016\/j.vascn.2016.05.011_bb0220","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0024-3205(81)90747-5","article-title":"Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors","volume":"28","author":"Leysen","year":"1981","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2016.05.011_bb0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3940(90)90604-8","article-title":"D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-d-aspartate (NMDA) antagonist: Effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801","volume":"113","author":"Lowe","year":"1990","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.vascn.2016.05.011_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(94)00733-N","article-title":"Discriminative effects of esteratic local anesthetics in squirrel monkeys","volume":"274","author":"Mansbach","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0235","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0022-3565(24)29229-6","article-title":"Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans","volume":"299","author":"Marsch","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-2999(98)00401-4","article-title":"In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones","volume":"353","author":"Mathiesen","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00435858","article-title":"Discriminative stimulus properties of arecoline: A new approach for studying central muscarinic receptors","volume":"75","author":"Meltzer","year":"1981","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.vascn.2016.05.011_bb0250","series-title":"Drug registration requirements in Japan, published by the new drug division","author":"MHLW","year":"1994"},{"key":"10.1016\/j.vascn.2016.05.011_bb0255","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pa.29.040189.002053","article-title":"The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system","volume":"29","author":"Monaghan","year":"1989","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0260","first-page":"19","article-title":"The antinociceptive activity of flupirtine: A structurally new analgesic","volume":"63","author":"Nickel","year":"1987","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.vascn.2016.05.011_bb0265","first-page":"1402","article-title":"Untersuchungen Zum Wirkungsmechanismus des Analgetikums Flupirtin","volume":"35","author":"Nickel","year":"1985","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"key":"10.1016\/j.vascn.2016.05.011_bb0270","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0960-894X(97)00347-8","article-title":"Identification of novel (isoxazole)methylene-1-azabicyclic compounds with high affinity for the central nicotinic cholinergic receptor","volume":"7","author":"Olesen","year":"1997","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.vascn.2016.05.011_bb0275","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0968-0896(98)00101-1","article-title":"3-(5-Alkylamino-4-Isoxazolyl)-1,2,5,6-tetrahydropyridines: A novel class of central nicotinic receptor ligands","volume":"6","author":"Olesen","year":"1998","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.vascn.2016.05.011_bb0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1213\/01.ANE.0000184254.85567.80","article-title":"A novel molecule with peripheral opioid properties: the effects on hypercarbic and hypoxic ventilation at steady-state compared with morphine and placebo","volume":"102","author":"\u00d6sterlund Modalen","year":"2006","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.vascn.2016.05.011_bb0285","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1213\/00000539-199901000-00030","article-title":"The effects on resting ventilation of intravenous infusions of morphine or sameridine, a novel molecule with both local anesthetic and opioid properties","volume":"88","author":"\u00d6sterlund","year":"1999","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.vascn.2016.05.011_bb0290","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(25)33409-9","article-title":"Separate noradrenergic receptors could mediate clonidine-induced antinociception","volume":"223","author":"Paalzow","year":"1982","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0026-895X(25)10925-5","article-title":"[3H]cytisine binding to nicotinic cholinergic receptors in brain","volume":"39","author":"Pabreza","year":"1990","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0300","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.1981.tb02397.x","article-title":"Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain","volume":"36","author":"Pedigo","year":"1981","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.vascn.2016.05.011_bb0305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF00506512","article-title":"L-654,284 a new potent and selective \u03b12-adrenoceptor antagonist","volume":"333","author":"Pettibone","year":"1986","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0310","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0376-8716(91)90081-9","article-title":"Abuse potential and pharmacological comparison of tramadol and morphine","volume":"27","author":"Preston","year":"1991","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.vascn.2016.05.011_bb0320","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"345","article-title":"Hypnotics and sedatives; ethanol","author":"Rall","year":"1990"},{"key":"10.1016\/j.vascn.2016.05.011_bb0325","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/316126a0","article-title":"Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs","volume":"316","author":"Richardson","year":"1985","journal-title":"Nature (London)"},{"key":"10.1016\/j.vascn.2016.05.011_bb0330","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"311","article-title":"Local anesthetics","author":"Ritchie","year":"1990"},{"key":"10.1016\/j.vascn.2016.05.011_bb0335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-9673(97)00517-7","article-title":"Enantiomeric separation of a tetrapeptide with cyclodextrin extension of the model for chiral capillary electrophoresis by complex formation of one enantiomer molecule with more than one chiral selector molecules","volume":"782","author":"S\u00e4nger-van de Griend","year":"1997","journal-title":"Journal of Chromatography. A"},{"key":"10.1016\/j.vascn.2016.05.011_bb0340","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0022-3565(25)23194-9","article-title":"Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-d-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice","volume":"256","author":"Schaus Arts","year":"1991","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"571\u2013574","key":"10.1016\/j.vascn.2016.05.011_bb0345","first-page":"1990","article-title":"2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia","volume":"247","author":"Sheardown","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vascn.2016.05.011_bb0350","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3565(25)10945-2","article-title":"Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice","volume":"262","author":"Smith","year":"1992","journal-title":"Journal Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(25)25945-6","article-title":"Antiserotonin-antihistaminic properties of cyproheptadine","volume":"131","author":"Stone","year":"1961","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0360","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00178974","article-title":"Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and \u03b2-endorphin in mice","volume":"342","author":"Suh","year":"1990","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0365","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/FBP.0b013e328363d1e2","article-title":"A proactive nonclinical drug abuse and dependence liability assessment strategy: A sponsor perspective","volume":"24","author":"Swedberg","year":"2013","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0370","series-title":"Paper presented to the Safety Pharmacology Society International Meeting, Prague, Czech Republic, September 28\u2013Oct 1","article-title":"Critical role for drug discrimination studies in the assessment of abuse liability of novel compounds","author":"Swedberg","year":"2015"},{"key":"10.1016\/j.vascn.2016.05.011_bb0375","series-title":"Nonclinical assessment of abuse potential for new pharmaceuticals","first-page":"129","article-title":"Drug discrimination: Use in preclinical assessment of abuse liability","author":"Swedberg","year":"2015"},{"key":"10.1016\/j.vascn.2016.05.011_bb0380","first-page":"86","article-title":"ATPA drug discrimination: a model of AMPA agonistic effects in vivo","volume":"18","author":"Swedberg","year":"1992","journal-title":"Society for Neuroscience \u2013 Abstracts"},{"key":"10.1016\/j.vascn.2016.05.011_bb9400","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(25)10570-3","article-title":"Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX)","volume":"274","author":"Swedberg","year":"1995","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0385","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.114.215137","article-title":"AZD9272 and AZD2066: Selective and highly CNS penetrant mGluR5 antagonists characterized by their discriminative effects","volume":"350","author":"Swedberg","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0390","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)22194-2","article-title":"Pharmacological mechanisms of action of flupirtine: A novel, centrally acting, non-opioid analgesic, evaluated by its discriminative effects in the rat","volume":"246","author":"Swedberg","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0395","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0022-3565(25)10433-3","article-title":"D-16949 (anpirtoline): A novel serotonergic (5-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat","volume":"263","author":"Swedberg","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0400","first-page":"1262","article-title":"NNC 90-0270: In vivo characterization of a novel centrally acting nicotinic agonist","volume":"22","author":"Swedberg","year":"1996","journal-title":"Society for Neuroscience \u2013 Abstracts"},{"key":"10.1016\/j.vascn.2016.05.011_bb0405","first-page":"888","article-title":"Analgesic and discriminative effects of LEF553, a peripherally acting \u03bc-opioid","volume":"24","author":"Swedberg","year":"1998","journal-title":"Society for Neuroscience \u2013 Abstracts"},{"key":"10.1016\/j.vascn.2016.05.011_bb0410","first-page":"2271","article-title":"Sameridine, a local anesthetic and analgesic opioid assessed by its discriminative effects in the rat","volume":"26","author":"Swedberg","year":"2000","journal-title":"Society for Neuroscience \u2013 Abstracts"},{"key":"10.1016\/j.vascn.2016.05.011_bb0415","article-title":"Similarities in the discriminative effects of short and long duration intravenous infusions of morphine in the rat. Program No. 900","author":"Swedberg","year":"2002"},{"key":"10.1016\/j.vascn.2016.05.011_bb0420","series-title":"a peripherally acting \u03bc-opioid. Program No. 110.18 Neuroscience Meeting Planner","article-title":"Discriminative effects of LEF576 (frakefamide)","author":"Swedberg","year":"2003"},{"key":"10.1016\/j.vascn.2016.05.011_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.113.211185","article-title":"mGluR5 Antagonist induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties","volume":"349","author":"Swedberg","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.011_bb0430","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(80)90444-6","article-title":"Antagonist\/agonist-preferring \u03b1-adrenoceptors or \u03b11\/\u03b12-adrenoceptors?","volume":"63","author":"Tanaka","year":"1980","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.011_bb0435","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-6147(84)90437-1","article-title":"Alpha1 and Alpha2: A selection of the select","volume":"5","author":"Triggle","year":"1984","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2016.05.011_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1748-1716.1978.tb06210.x","article-title":"Differentiation between pre-and postjunctional \u03b1-receptors in the Guinea pig ileum and rabbit aorta","volume":"103","author":"Wikberg","year":"1978","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/j.vascn.2016.05.011_bb0440","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0091-3057(99)00059-3","article-title":"Cannabis: Discrimination of \u201cinternal bliss\u201d?","volume":"64","author":"Wiley","year":"1999","journal-title":"Pharmacology, Biochemistry, and Behavior"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687191630051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687191630051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:02:20Z","timestamp":1761004940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687191630051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":90,"alternative-id":["S105687191630051X"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.011","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}